High specificity makes DNA screening the method of choice for diagnosis of familial hypercholesterolaemia

dc.contributor.author	Kotze, M. J.	en_ZA
dc.date.accessioned	2011-03-18T14:57:04Z
dc.date.available	2011-03-18T14:57:04Z
dc.date.issued	2001
dc.description	CITATION: Kotze, M. J. 2001. High specificity makes DNA screening the method of choice for diagnosis of familial hypercholesterolaemia. South African Medical Journal, 91(12):1042.
dc.description	The original publication is available at http://www.samj.org.za
dc.description.abstract	The diagnosis of familial hypercholesterolaemia (PH) is based on clinical findings, a family history of premature atherosclerosis and elevated plasma cholesterol levels.' Identification of heterozygous PH is complicated by the fact that biochemical parameters may overlap between normal and affected individuals, especially in children! and most adult patients do not present with cholesterol deposits in the skin and tendons. The importance of a DNA test that can provide a simple yes/no answer has now been demonstrated clearly in the article by Vergotine and colleagues in this issue of the Journal.
dc.description.version	Publisher’s version
dc.format.extent	1 page
dc.identifier.issn	2078-5135 (online)
dc.identifier.issn	0256-9574 (print)
dc.identifier.uri	http://hdl.handle.net/10019.1/7166
dc.language.iso	en
dc.publisher	Health & Medical Publishing Group
dc.rights.holder	South African Medical Journal
dc.subject	Hypercholesterolaemia	en_ZA
dc.title	High specificity makes DNA screening the method of choice for diagnosis of familial hypercholesterolaemia	en_ZA
dc.type	Article

Now showing 1 - 1 of 1